T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Financials | 10.75% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Oxford Industries
OXM
$534M
| $10.6M | ﹤0.01% |
116,657
+5,046
| +5% | +$446K |
|
1352
Douglas Dynamics
PLOW
$974M
| $10.5M | ﹤0.01% |
304,916
-2,671
| -0.9% | -$97.1K |
|
1353
GitLab
GTLB
$7.23B
| $10.4M | ﹤0.01% |
190,473
-349,320
| -65% | -$20.8M |
|
1354
Emergent Biosolutions
EBS
$239M
| $10.3M | ﹤0.01% |
251,689
-20,384
| -7% | -$899K |
|
1355
PENN Entertainment
PENN
$2.53B
| $10.3M | ﹤0.01% |
242,389
-13,737
| -5% | -$628K |
|
1356
Immunocore
IMCR
$1.73B
| $10.3M | ﹤0.01% |
343,279
-36,612
| -10% | -$924K |
|
|
INFN
1357
DELISTED
Infinera Corporation Common Stock
INFN
| $10.3M | ﹤0.01% |
1,183,121
-1,806
| -0.2% | -$15.5K |
|
1358
Frontier Group Holdings
ULCC
$1.54B
| $10.2M | ﹤0.01% |
899,458
+27,115
| +3% | +$341K |
|
|
EB
1359
DELISTED
Eventbrite
EB
| $10.2M | ﹤0.01% |
688,726
+29,793
| +5% | +$442K |
|
1360
Berkshire Hathaway Class A
BRK.A
$1.08T
| $10M | ﹤0.01% |
19
| – | – |
|
1361
Trinity Capital Inc.
TRIN
$1.72B
| $9.97M | ﹤0.01% |
516,409
-956
| -0.2% | -$17.1K |
|
|
AQUA
1362
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $9.81M | ﹤0.01% |
208,800
+176,138
| +539% | +$7.52M |
|
1363
Hydrofarm Holdings
HYFM
$7.39M
| $9.71M | ﹤0.01% |
64,060
+3,657
| +6% | +$682K |
|
1364
Consensus Cloud Solutions
CCSI
$713M
| $9.47M | ﹤0.01% |
157,517
+7,311
| +5% | +$423K |
|
1365
ProPetro Holding
PUMP
$1.48B
| $9.44M | ﹤0.01% |
+677,910
| New | +$8.1M |
|
1366
Schrodinger
SDGR
$1.35B
| $9.42M | ﹤0.01% |
276,090
+5,861
| +2% | +$178K |
|
1367
Bloom Energy
BE
$68.9B
| $9.34M | ﹤0.01% |
386,566
-161,717
| -29% | -$3.16M |
|
1368
State Street Blackstone Senior Loan ETF
SRLN
$5.37B
| $9.33M | ﹤0.01% |
207,600
-279,500
| -57% | -$12.6M |
|
1369
Design Therapeutics
DSGN
$906M
| $9.27M | ﹤0.01% |
574,012
-213,653
| -27% | -$3.27M |
|
|
SMAR
1370
DELISTED
Smartsheet Inc.
SMAR
| $9.22M | ﹤0.01% |
168,263
-138,000
| -45% | -$7.88M |
|
|
CCXI
1371
DELISTED
ChemoCentryx, Inc.
CCXI
| $9.17M | ﹤0.01% |
365,634
-1,789
| -0.5% | -$50.3K |
|
1372
Chewy
CHWY
$9.17B
| $9.1M | ﹤0.01% |
223,083
-25,100
| -10% | -$1.14M |
|
1373
Silicon Laboratories
SLAB
$7.29B
| $9.07M | ﹤0.01% |
60,359
+1,592
| +3% | +$254K |
|
1374
Hayward Holdings
HAYW
$3.22B
| $8.94M | ﹤0.01% |
537,626
+517,493
| +2,570% | +$9.79M |
|
1375
Stoke Therapeutics
STOK
$2B
| $8.92M | ﹤0.01% |
423,863
-14,384
| -3% | -$288K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.